Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum

Immunological follow-up of patients with neuromyelitis optica: Is there a good biomarker?

(2012) J-B Chanson et al.   LUPUS

Rituximab dosing and monitoring strategies in neuromyelitis optica patients: creating strategies for therapeutic success

(2012) Benjamin M Greenberg et al.   Multiple Sclerosis Journal

Neuromyelitis optica following human papillomavirus vaccination

(2012) T. Menge et al.   NEUROLOGY

Neuromyelitis optica and pregnancy

(2012) B. Bourre et al.   NEUROLOGY

Influence of pregnancy on neuromyelitis optica spectrum disorder

(2012) W. Kim et al.   NEUROLOGY

Repeated Treatment With Rituximab Based on the Assessment of Peripheral Circulating Memory B Cells in Patients With Relapsing Neuromyelitis Optica Over 2 Years

(2011) Su-Hyun Kim   ARCHIVES OF NEUROLOGY

Course of neuromyelitis optica during inadvertent pregnancy in a patient treated with rituximab

(2009) HL Pellkofer et al.   Multiple Sclerosis Journal

Treatment of Neuromyelitis Optica With Rituximab

(2008)   ARCHIVES OF NEUROLOGY

Antibody to aquaporin-4 in the long-term course of neuromyelitis optica

(2008) S. Jarius et al.   BRAIN